Group C also showed the highest ratio of CD8+ TILs to tumor-infiltrating Treg cells (all P < 0.0001 when compared to Groups A, B, and PBS-treatment), suggesting a more favorable TME for effector T-cell responses than in other groups (Fig. 4B, left panel). The gene discussed is CD8A; the disease is neoplasm.